Danaher Corporation
(
DHR
) is set to report its fourth quarter 2012 results on Jan 29. The
company reported a negative surprise of 1.3% in the last quarter.
Let's see how things are shaping up for this announcement.
Growth Factors This Past Quarter
Danaher was affected by the economic downturn, lower demand
for some of its core products and negative currency translation
in the previous quarter. The company's sales growth rates in the
quarter were down 3% on a year-over-year basis.
The company reported revenue declines in three (Test &
Measurement, Life Sciences and Diagnostics and Dental) of its
five operating segments and was also hurt by weak demand in its
Instruments business. The Communications business also
disappointed due to the lack of large carrier projects.
Earnings Whispers?
Our proven model does not conclusively show that Danaher is
likely to beat estimates this quarter. This is because a stock
needs to have both positive Earnings ESP and Zacks Rank #1, #2 or
#3 for this to happen. That is not the case here as you will see
below:
Zacks ESP:
Danaher has a
Zacks Earnings ESP
of 0.00%
Zacks Rank #3 (Hold):
Danaher's Zacks Rank #3 (Hold) lowers the predictive power of ESP
because the Zacks Rank #3 when combined with a 0.00% ESP
makes surprise prediction difficult. We caution against stocks
with Zacks #4 and #5 Ranks (Sell rated stocks) going into the
earnings announcement, especially when the company is seeing
negative estimate revisions momentum.
Other Stocks to Consider
Here are some other companies you may want to consider as our
model shows they have the right combination of elements to post
an earnings beat this quarter:
Idex Corp.
(
IEX
) Earnings ESP of 1.49% and Zacks Rank #2 (Buy)
Broadcom Corp.
(
BRCM
) Earnings ESP of 1.9% and Zacks #2 Rank (Buy)
Geospace Technology Corporation
(
GEOS
) Earnings ESP of 21.2% and Zacks Rank # 2 (Buy)
BROADCOM CORP-A (BRCM): Free Stock Analysis
Report
DANAHER CORP (DHR): Free Stock Analysis
Report
GEOSPACE TEC CP (GEOS): Free Stock Analysis
Report
IDEX CORP (IEX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment
Research